Log in

OTCMKTS:BLOZFCannabix Technologies Stock Price, Forecast & News

$0.31
+0.01 (+3.37 %)
(As of 05/22/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.29
Now: $0.31
$0.31
50-Day Range
$0.26
MA: $0.30
$0.37
52-Week Range
$0.23
Now: $0.31
$1.00
Volume73,978 shs
Average Volume127,745 shs
Market Capitalization$31.88 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Cannabix Technologies Inc., a technology company, develops marijuana breathalyzer for law enforcement and the work place in North America. It develops drug-testing devices that will detect tetrahydrocannabinol using breath samples at roadside and identify drivers under the influence of marijuana. The company was formerly known as West Point Resources Inc. and changed its name to Cannabix Technologies Inc. in August 2014. Cannabix Technologies Inc. was incorporated in 2011 and is based in Burnaby, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.64 out of 5 stars


Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorBusiness Services
Current SymbolOTCMKTS:BLOZF
CUSIPN/A
CIKN/A
WebN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Market Cap$31.88 million
Next Earnings DateN/A
OptionableNot Optionable

Receive BLOZF News and Ratings via Email

Sign-up to receive the latest news and ratings for BLOZF and its competitors with MarketBeat's FREE daily newsletter.

Cannabix Technologies (OTCMKTS:BLOZF) Frequently Asked Questions

How has Cannabix Technologies' stock been impacted by COVID-19 (Coronavirus)?

Cannabix Technologies' stock was trading at $0.38 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BLOZF shares have decreased by 19.3% and is now trading at $0.3065. View which stocks have been most impacted by Coronavirus.

Has Cannabix Technologies been receiving favorable news coverage?

Media headlines about BLOZF stock have trended neutral recently, according to InfoTrie Sentiment. The research firm scores the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Cannabix Technologies earned a news sentiment score of 0.1 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news aboutCannabix Technologies.

Who are some of Cannabix Technologies' key competitors?

Who are Cannabix Technologies' key executives?

Cannabix Technologies' management team includes the following people:
  • Mr. Ravinder S. Mlait B.A., M.B.A., BA, MBA, CEO & Director (Age 43)
  • Mr. Kulwant Sing Malhi, Pres & Director (Age 52)
  • Mr. Bryan E. Loree CPA, C.M.A., B.A., CMA, CFO, Corp. Sec. & Director (Age 43)
  • Dr. Rajpaul Attariwala, Chief Scientific Officer & Director (Age 51)
  • Dr. Marilyn Huestis, Consultant & Scientific Advisor

What is Cannabix Technologies' stock symbol?

Cannabix Technologies trades on the OTCMKTS under the ticker symbol "BLOZF."

How do I buy shares of Cannabix Technologies?

Shares of BLOZF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Cannabix Technologies' stock price today?

One share of BLOZF stock can currently be purchased for approximately $0.31.

How big of a company is Cannabix Technologies?

Cannabix Technologies has a market capitalization of $31.88 million.

This page was last updated on 5/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.